Design, synthesis, and pharmacological characterization of N- and O-substituted 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol analogues: novel 5-HT(2A)/5-HT(2C) receptor agonists with pro-cognitive properties

Research output: Contribution to journalJournal articleResearchpeer-review

Anders A Jensen, Niels Plath, Martin H. F. Pedersen, Vignir Isberg, Jacob Krall, Petrine Wellendorph, Tine B. Stensbøl, David E. Gloriam, Povl Krogsgaard-Larsen, Bente Frølund

The isoxazol-3-one tautomer of the bicyclic isoxazole, 5,6,7,8-tetrahydro-4H-isoxazolo[4,5-d]azepin-3-ol (THAZ), has previously been shown to be a weak GABA(A) and glycine receptor antagonist. In the present study, the potential in this scaffold has been explored through the synthesis and pharmacological characterization of a series of N- and O-substituted THAZ analogues. The analogues N-Bn-THAZ (3d) and O-Bn-THAZ (4d) were found to be potent agonists of the human 5-HT(2A) and 5-HT(2C) receptors. Judging from an elaborate pharmacological profiling at numerous other CNS targets, the 3d analogue appears to be selective for the two receptors. Administration of 3d substantially improved the cognitive performance of mice in a place recognition Y-maze model, an effect fully reversible by coadministration of the selective 5-HT(2C) antagonist SB242084. In conclusion, as novel bioavailable cognitive enhancers that most likely mediate their effects through 5-HT(2A) and/or 5-HT(2C) receptors, the isoxazoles 3d and 4d constitute interesting leads for further medicinal chemistry development.
Original languageEnglish
JournalJournal of Medicinal Chemistry
Volume56
Issue number3
Pages (from-to)1211-27
Number of pages17
ISSN0022-2623
DOIs
Publication statusPublished - 14 Feb 2013

    Research areas

  • Azepines, Biological Availability, Cognition, Drug Design, HEK293 Cells, Humans, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Serotonin Receptor Agonists

ID: 45811135